About Ntouch Research
Ntouch Research is a company based in Raleigh (United States) founded in 1997 was acquired by Accelovance in February 2005.. Ntouch Research has raised $9 million across 2 funding rounds from investors including Canaan, Accelovance and Intersouth Partners. Ntouch Research operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Raleigh, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9 M (USD)
in 2 rounds
-
Latest Funding Round
$8 M (USD), Private Equity Round
Feb 17, 2000
-
Investors
Canaan
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Accelovance
(Feb 04, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ntouch Research
Ntouch Research has successfully raised a total of $9M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $8 million completed in February 2000. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Private Equity Round — $8.0M
-
First Round
First Round
(01 Jun 1998)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2000 | Amount | Private Equity Round - Ntouch Research | Valuation |
investors |
|
| Jun, 1998 | Amount | Unspecified - Ntouch Research | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ntouch Research
Ntouch Research has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Canaan, Accelovance and Intersouth Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Founded Year | Domain | Location | |
|
Investment in emerging and growth-stage MedTech companies is facilitated.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ntouch Research
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ntouch Research
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ntouch Research Comparisons
Competitors of Ntouch Research
Ntouch Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for cancer and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
CRO clinical development services are provided by Syneos Health.
|
|
| domain | founded_year | HQ Location |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| domain | founded_year | HQ Location |
Outsourced contract research organization services are provided to clients.
|
|
| domain | founded_year | HQ Location |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| domain | founded_year | HQ Location |
Global full-service CRO services are delivered in over 80 countries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ntouch Research
Frequently Asked Questions about Ntouch Research
When was Ntouch Research founded?
Ntouch Research was founded in 1997 and raised its 1st funding round 1 year after it was founded.
Where is Ntouch Research located?
Ntouch Research is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Is Ntouch Research a funded company?
Ntouch Research is a funded company, having raised a total of $9M across 2 funding rounds to date. The company's 1st funding round was a Unspecified of $1M, raised on Jun 01, 1998.
What does Ntouch Research do?
Ntouch Research was established in 1997 in Raleigh, United States, as a full-service contract research organization in the clinical trials sector. Complete management services are provided for Phase I through post-approval Phase IV studies, encompassing site management, monitoring, data management, biostatistics, health economics, and medical and regulatory affairs. All facilities are maintained in compliance with ICH and GCP standards.
Who are the top competitors of Ntouch Research?
Ntouch Research's top competitors include Emmes, Syneos Health and ClinChoice.
Who are Ntouch Research's investors?
Ntouch Research has 4 investors. Key investors include Canaan, Accelovance, Intersouth Partners, and BioVentures MedTech Funds.